MAMUNES: SCREENING FOR GENETIC DISEASE
age separation of all urinary amino acids to detect
any excesses. Although the yield of newly diagnosed
inborn errors by this screening program is small,
those few cases detect~d are important because they
may le;id to a specific diagnosis that permits a prognosis, a recurrence risk for other family members,
and counseling about the possibility of treatment or
prenatal diagnosis for future pregnancies.
Clearly, genetic screening programs are an important component of the primary care physician's
efforts in preventive medicine. Participation in and
support of these programs is therefore strongly
urged.
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The Virginia Sickle Cell Anemia Awareness
Program (VaSCAP): Education, Screening,
and Counseling
FLORENCE N. COOPER AND ROBERT B. SCOTT, M.D., Department of Medicine

In 1968, a program of screening for sickle trait
carriers was begun as part of the work of the Hematology Division, Department of j'vtedicine, at the
Medical College of Virginia. It was felt that sickle cell
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anemia was more of a public health problem than
was generally recognized, and in addition to institutipg screening and education programs, data were collected to document the rela tive neglect of the problem.
A survey of the Cjty of Richmond was conducted to ascertain the level of awareness among
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black adults of sickle cell anemia, a severe chronic
disease affecting one of every 500 black babies. The
results' showed that only 3 of every IO black adults
had ever heard of this disease, and of those who
recognized it, few understood the nature of the illness. Additional background information was collected which further showed the lack of professional
and public understanding of the importance of sickle
cell anemia as a public health problem. These data, 2 •3
which attracted widespread attention, showed that
sickle cell anemia research received far less support
than other much Jess common chronic illnesses.
Public attention was also focused on sickle cell
anemia by publicity concerning a new "test tube" test
for sickling, and claims for therapeutic benefit from
intravenous urea solutions. The heightened interest in
sickle cell disease finally resulted in the Sickle Cell
Anemia Prevention Act of 1972, which included a
series of sickle cell research a nd treatment centers
plus screening, education, and counseling clinics
throughout the nation. At that time VaSCAP competed successfully for a contract under the national
program, and expanded from a small screening effort
to a larger, well-staffed clinic which could extend its
effects state-wide.
Although the ability to detect healthy carriers of
the recessive sickle trait had existed for years, no
widespread screening and genetic counseling had
taken place prior to these new programs. Another
factor which made mass screening economically feasible was the development of rapid, simple instruments for performing hemoglobin electrophoresis. Electrophoresis has distinct adva ntages
over the classical sickle cell "prep" or the.newer test
tube tests since it can distinguish sickle trait from the
homozygous state, sickle cell anemia, and can also
detect numerous other hemoglobin variants.
The purpose of screening for abnormal hemoglobins is to give young people a n opportunity, not
previously available, to know in advance of childbearing whether they run the risk of having children
with sickle cell anemia. The frequency of sickle tr<1it is
about 8% of the black population, or I in every 12
blacks. The chance, then, that both potential parents
in a couple a re trait carriers is I in 144; thus slightly
less than I% of bl ack couples are composed of two
trait carriers and are at risk for bearing children with
sickle cell anemia . The chance is I in 4 with each
pregnancy that a child will be born with this incurable
illness.
Screening should not be performed without ade-

quate prior education. To implement this principle,
VaSCAP has developed a number of audiovisual
programs and written materials suitable for a wide
variety of audiences. Included in these are the Sickle
Cell Anemia Fact Book, 4 a booklet for teachers,
nurses, and other professionals, and Our Sickle Cell
Story Fact Book, 5 for elementary and middle school
students. These, as well as brochures, posters, and
fact sheets are distributed through the Virginia State
Department of Health, to many areas of Virginia and
throughout the nation. Since its inception, VaSCAP
has provided educational sessions to over 200,000
individuals in groups of various sizes. It has also
reached many more through programs, spot announcements, and structured educational models for
specific target groups with the result that screening
for hemoglobin genes has become an acceptable procedure among the general population. At present
over 42,000 persons have been screened by hemoglobin electrophoresis and 3,951 have been found to
have hemoglobin variants.
The ultimate result of education and screening is
counseling those found to have sickle or other mutant
hemoglobin genes. Counseling is aimed at educating
the individual so that he or she can know the nature
of the sickle gene, understand what sickle cell anemia
is, understand the probabilities of transmitting the
genes, and then be able to make informed decisions
about childbearing.There is a set of slides available
which has been developed by the VaSCAP staff.
These explain the probabilities of inheritance for each
specific hemoglobin variant. Individuals newly diagnosed with sickle cell anemia or one of its variants
have been referred to a family physician or to the
Hematology Clinic at MCV.
Approximately 8% of Virginia blacks have been
found to have sickle cell trait, and 2% carry hemoglobin C trait. About 0.3% have the gene for hereditary
persistence of fetal hemoglobin (HPFH), which is a
gene mutation not associated with any disease. In
addition, a large number of less common mutant
hemoglobin genes have been recognized .
Though the alkaline electrophoresis test is the
primary method used for the detection of hemoglobin
genes, there are other methods which may be required in order to provide more conclusive results.
The laboratory of the VaSCAP clinic provides both
alk aline a nd acid or citrate agar electrophoresis. A2
mini-columns for hemoglobin A 2 qua ntitations are
very useful in detecting the Beta thalassemias; fetal
hemoglobin staining aids in determining the presence
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of HPFH . Family studies are necessary in certain
cases and the clinic has screened as many as four
generations in some families.
All of the services have been provided without
charge to the public or physicians for whom diagnostic testing has been performed . The emphasis has
been on testing persons in or approaching the childbearing age.
Education programs have been carried out in
most high schools and colleges in central Virginia and
the Tidewater area. Church groups and community
organizations regularly request programs, many of
which are provided in evenings or on weekends . An
important part of the educational effort has been to
provide workshops to train public health nurses in
genetic counseling relating to hemoglobinopathies.
State legislstion has provided funds for nurses to be
designated as genetic counselors in all of the Health
Department clinics in the State. VaSCAP has also
worked closely with local health departments in providing consultations concerning diagnosis and counseling of individuals with unusual hemoglobin variants .
The number of individuals served by the VaSCAP clinic is a tangible measure of its performance,
but it does not reflect all of the benefits to the public
and health professionals. The tragic lack of public
awareness of the importance of sickle cell anemia that
characterized the beginnings of this program has disappeared. For health professionals, especially at
MCV, the subject of hemoglobinopathies has been
emphasized repeatedly, and the level of interest and
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understanding of the disease and its variants have
risen considerably. Of particular significance are the
improved diagnostic facilities provided by VaSCAP
clinics which have made it possible to stress the more
rigorous modern standard of diagnosis for hemoglobin disorders .6 Perhaps most important to the field of
genetics generally has been the extensive practical
experience gained by the first mass screening efforts
for a heritable disease. The ease with which recessive
hemoglobin genes are detected made it the first such
program to be implemented; as additional gene tests
are developed, other genetic diseases will be the targets of similar programs.
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